<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03908892</url>
  </required_header>
  <id_info>
    <org_study_id>2019KT1122</org_study_id>
    <nct_id>NCT03908892</nct_id>
  </id_info>
  <brief_title>Effect of Zanthoxylum Nitidum Tincture for Paronychia Caused by Afatinib</brief_title>
  <official_title>A Clinical Study on the Treatment of Paronychia Caused by Afatinib With Zanthoxylum Nitidum Tincture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou University of Traditional Chinese Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized control trial evaluating the efficacy of zanthoxylum nitidum tincture on
      preventing progression of paronychia caused by afatinib from grade 1 to grade 2/3. Enrolled
      participates will randomly receive original treatment or original treatment plus zanthoxylum
      nitidum tincture immersion of the sick nail(s).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 12, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Paronychia progress rate</measure>
    <time_frame>Through study completion, an average of 10 days.</time_frame>
    <description>Incidence of grade 2 or more paronychia during paronychia treatment period will be reported. This period will be from randomization till paronychia relief or progression. Frequency of evaluation for paronychia will be everyday.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to paronychia progress</measure>
    <time_frame>Through study completion, an average of 10 days.</time_frame>
    <description>The time elapsed from randomization to either the date of grade 2 or more paronychia occurrence, treatment completion, or last follow-up information. Frequency of evaluation for paronychia will be everyday.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to paronychia relief</measure>
    <time_frame>Through study completion, an average of 10 days.</time_frame>
    <description>The time elapsed from randomization to either the date of paronychia relief, treatment completion, or last follow-up information. Paronychia relief is defined as that paronychia disappears. Frequency of evaluation for paronychia will be everyday.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Paronychia</condition>
  <arm_group>
    <arm_group_label>Combination group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Local use of 1% tetracycline ointment for the sick nail(s), 3 times a day, plus local application with zanthoxylum nitidum tincture soaked blocks for the sick nail(s) for 30 minutes, twice a day, till paronychia relief or progression.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local use of 1% tetracycline ointment for the sick nail(s), 3 times a day, till paronychia relief or progression.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>zanthoxylum nitidum tincture</intervention_name>
    <description>Local application with zanthoxylum nitidum tincture soaked blocks for the sick nail(s) for 30 minutes, twice a day.</description>
    <arm_group_label>Combination group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tetracycline ointment</intervention_name>
    <description>Local use of 1% tetracycline ointment for the sick nail(s), 3 times a day</description>
    <arm_group_label>Combination group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Pathologically or cytologically confirmed non-small cell lung cancer；

          2. Undergoing treatment with afatinib；

          3. With grade 1 paronychia；

          4. Age between 18 to 80 years old；

          5. Estimated life expectancy of more than months；

          6. With the written informed consent.

        Exclusion Criteria:

          1. Paronychia before afatinib treatment;

          2. Grade 2 or severer paronychia;

          3. Stop using afatinib or with reduced dose of afatinib;

          4. Currently diagnosed with severe encephalopathy or psychiatric disorders affecting
             patients ability of self expression.

          5. Has other legal, medical or ethical reasons that patients are not appropriate for
             clinical study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yanjuan Zhu, Dr</last_name>
    <phone>86 20 81887233</phone>
    <phone_ext>34830</phone_ext>
    <email>zyjsophy@gzucm.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yihong Liu, Dr</last_name>
    <phone>80 20 81887233</phone>
    <phone_ext>34830</phone_ext>
    <email>yihongl@gzucm.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guangdong Provincial Hospital of Chinese Medicine</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanjuan Zhu, Dr.</last_name>
      <phone>86 20 81887233</phone>
      <phone_ext>34830</phone_ext>
      <email>zyjsophy@gzucm.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Yihong Liu, Dr.</last_name>
      <phone>86 20 81887233</phone>
      <phone_ext>34830</phone_ext>
      <email>yihongl@gzucm.edu.cn</email>
    </contact_backup>
    <investigator>
      <last_name>Haibo Zhang, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 21, 2019</study_first_submitted>
  <study_first_submitted_qc>April 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2019</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou University of Traditional Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Haibo Zhang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Paronychia</keyword>
  <keyword>Zanthoxylum nitidum tincture</keyword>
  <keyword>Afatinib</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paronychia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tetracycline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

